COVID-19 vaccines and people with cancer
January 28, 2021
UPDATED: April 30, 2021
The COVID-19 pandemic continues to affect many Canadians, including those in high-risk and vulnerable populations. As different types of vaccines are becoming available to protect against the coronavirus, specific evidence on their safety and efficacy for people with cancer is still being established.
If you are living with ovarian cancer, Ovarian Cancer Canada recommends that you consult your oncologist before proceeding with vaccinations for COVID-19. This ensures you receive personalized, expert advice based on your unique circumstances.
Alongside a collective of patient organizations, Ovarian Cancer Canada is advocating for people in high-risk and vulnerable populations to be prioritized ahead of the general population in the rollout of vaccines. This is consistent with guidance from Canada’s National Advisory Committee on Immunization.
Already, we have sent a joint letter to Patty Hajdu, Minister of Health, appealing for her to urge provincial and territorial health ministers to prioritize people living with certain chronic conditions (including cancer) who are at high risk of severe illness or death from COVID-19.
Vaccine rollout plans are currently being implemented in the provinces and territories. More information can be found on the Government of Canada website and please consult with your doctor or health care provider if you have questions or concerns.
As always, Ovarian Cancer Canada is informed by the best available evidence and information from health experts and authorities. Our team is closely monitoring developments as they occur and will be updating ovariancanada.org with further details.